BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28622441)

  • 1. Cardiovascular mortality among liver transplant recipients with nonalcoholic steatohepatitis in the United States-a retrospective study.
    Satapathy SK; Jiang Y; Eason JD; Kedia SK; Wong E; Singal AK; Tolley EA; Hathaway D; Nair S; Vanatta JM
    Transpl Int; 2017 Oct; 30(10):1051-1060. PubMed ID: 28622441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
    Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
    Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.
    Cholankeril G; Wong RJ; Hu M; Perumpail RB; Yoo ER; Puri P; Younossi ZM; Harrison SA; Ahmed A
    Dig Dis Sci; 2017 Oct; 62(10):2915-2922. PubMed ID: 28744836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Nonmalignant Portal Vein Thrombosis in Transplant Recipients With Nonalcoholic Steatohepatitis.
    Agbim U; Jiang Y; Kedia SK; Singal AK; Ahmed A; Bhamidimarri KR; Bernstein DE; Harrison SA; Younossi ZM; Satapathy SK
    Liver Transpl; 2019 Jan; 25(1):68-78. PubMed ID: 30091296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of renal impairment on cardiovascular disease mortality after liver transplantation for nonalcoholic steatohepatitis cirrhosis.
    VanWagner LB; Lapin B; Skaro AI; Lloyd-Jones DM; Rinella ME
    Liver Int; 2015 Dec; 35(12):2575-83. PubMed ID: 25977117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Risk of Death in First Year After Liver Transplantation Among Patients With Nonalcoholic Steatohepatitis vs Liver Disease of Other Etiologies.
    Nagai S; Collins K; Chau LC; Safwan M; Rizzari M; Yoshida A; Abouljoud MS; Moonka D
    Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2759-2768.e5. PubMed ID: 31004758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.
    Wong RJ; Aguilar M; Cheung R; Perumpail RB; Harrison SA; Younossi ZM; Ahmed A
    Gastroenterology; 2015 Mar; 148(3):547-55. PubMed ID: 25461851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.
    Castelló B; Aguilera V; Blázquez MT; Rubín Á; García M; Vinaixa C; Benlloch S; SanJuan F; Montalva E; López R; Berenguer M
    Ann Hepatol; 2019; 18(6):855-861. PubMed ID: 31543468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced impact of renal failure on the outcome of patients with alcoholic liver disease undergoing liver transplantation.
    Cheong J; Galanko JA; Arora S; Cabezas J; Ndugga NJ; Lucey MR; Hayashi PH; Barritt AS; Bataller R
    Liver Int; 2017 Feb; 37(2):290-298. PubMed ID: 27258535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of NASH cirrhosis in liver transplant waitlist registrants.
    Lim WH; Ng CH; Tan D; Tseng M; Xiao J; Yong JN; Zeng RW; Cho E; Tay P; Ang CZ; Koh JH; Teng M; Syn N; Kow A; Huang DQ; Tan EX; Rinella ME; Sanyal A; Muthiah M; Siddiqui MS
    J Hepatol; 2023 Oct; 79(4):1015-1024. PubMed ID: 37307997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved survival outcomes in patients with non-alcoholic steatohepatitis and alcoholic liver disease following liver transplantation: an analysis of 2002-2012 United Network for Organ Sharing data.
    Wong RJ; Chou C; Bonham CA; Concepcion W; Esquivel CO; Ahmed A
    Clin Transplant; 2014 Jun; 28(6):713-21. PubMed ID: 24654688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of Cardiovascular Events and Effect on Survival in Liver Transplant Recipients for Cirrhosis Due to Alcoholic or Nonalcoholic Steatohepatitis.
    Piazza NA; Singal AK
    Exp Clin Transplant; 2016 Feb; 14(1):79-85. PubMed ID: 26581602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma.
    Lewin SM; Mehta N; Kelley RK; Roberts JP; Yao FY; Brandman D
    Liver Transpl; 2017 Aug; 23(8):1015-1022. PubMed ID: 28340509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
    Goldberg D; Ditah IC; Saeian K; Lalehzari M; Aronsohn A; Gorospe EC; Charlton M
    Gastroenterology; 2017 Apr; 152(5):1090-1099.e1. PubMed ID: 28088461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation.
    Carter D; Dieterich DT; Chang C
    Clin Liver Dis; 2018 Feb; 22(1):213-227. PubMed ID: 29128058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation.
    Kern B; Feurstein B; Fritz J; Fabritius C; Sucher R; Graziadei I; Bale R; Tilg H; Zoller H; Newsome P; Eschertzhuber S; Margreiter R; Öfner D; Schneeberger S
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):205-210. PubMed ID: 30320609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis.
    Stepanova M; Henry L; Garg R; Kalwaney S; Saab S; Younossi Z
    BMC Gastroenterol; 2015 Dec; 15():175. PubMed ID: 26666336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Pretransplant Renal Function With Liver Graft and Patient Survival After Liver Transplantation in Patients With Nonalcoholic Steatohepatitis.
    Molnar MZ; Joglekar K; Jiang Y; Cholankeril G; Abdul MKM; Kedia S; Gonzalez HC; Ahmed A; Singal A; Bhamidimarri KR; Aithal GP; Duseja A; Wong VW; Gulnare A; Puri P; Nair S; Eason JD; Satapathy SK;
    Liver Transpl; 2019 Mar; 25(3):399-410. PubMed ID: 30369023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances.
    Noureddin M; Vipani A; Bresee C; Todo T; Kim IK; Alkhouri N; Setiawan VW; Tran T; Ayoub WS; Lu SC; Klein AS; Sundaram V; Nissen NN
    Am J Gastroenterol; 2018 Nov; 113(11):1649-1659. PubMed ID: 29880964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplant Outcomes in Older Patients With Nonalcoholic Steatohepatitis Compared to Alcohol-related Liver Disease and Hepatitis C.
    Henson JB; Wilder JM; Kappus MR; Barbas AS; Moylan CA; Niedzwiecki D; Muir AJ; Berg CL; Patel YA
    Transplantation; 2020 Jun; 104(6):e164-e173. PubMed ID: 32150036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.